Possible Links Between Inflammation and Lipid Metabolism
NCT03392701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2018-10-17
Summary
It has been recognized lately that sepsis and inflammation has an important impact on lipid metabolism and that the extent of hypocholesterolemia may even be a marker of severity of illness. However, the interplay between inflammation and the marked changes in lipid metabolism remain to be sufficiently understood. Importantly, the exact kinetics of lipid parameters in inflammatory conditions are yet to be explored. This study aims to investigate the interaction between inflammation and lipid metabolism using the human endotoxin model (LPS infusion) in ten healthy volunteers in a single blinded randomized placebo controlled cross-over design.
Conditions
- Sepsis
- Inflammation
- LPS
- Lipid Metabolism Disorder
Interventions
- BIOLOGICAL
-
LPS infusion
infusion of LPS 2 ng/kg over 5 minutes
Sponsors & Collaborators
-
Barmherzige Brüder Linz
lead OTHER
Principal Investigators
-
Matthias Heinzl, MD · Barmherzige Brüder Linz
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-12-20
- Primary Completion
- 2018-07-30
- Completion
- 2018-09-30
Countries
- Austria
Study Locations
More Related Trials
-
Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic Control
NCT01013662 ·Status: COMPLETED ·Phase: NA
-
The Role of Dysfunctional HDL in Sepsis
NCT02934997 ·Status: COMPLETED
-
Zinc and Inflammation in Sepsis
NCT01328509 ·Status: COMPLETED
-
Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis
NCT00187824 ·Status: UNKNOWN
-
Platelet-associated Inflammation in Severe Sepsis
NCT03029039 ·Status: COMPLETED
-
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis
NCT05110937 ·Status: RECRUITING
-
Adiposity and Immunometabolism in Sepsis
NCT06307509 ·Status: NOT_YET_RECRUITING
-
Early Prediction of Sepsis by Using Metabolomics
NCT03996759 ·Status: UNKNOWN
-
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
NCT06338124 ·Status: RECRUITING
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED
-
LIPIDS-P Trial Phase I/II Trial
NCT03405870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in Intensive Care Unit
NCT04635878 ·Status: COMPLETED
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Effect of Statin Therapy on Sepsis-related Mortality in Intensive Care Unit Patients
NCT06354452 ·Status: COMPLETED
-
The Role of Dysfunctional HDL in Severe Sepsis
NCT02370186 ·Status: COMPLETED
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Evaluation of the Prognostic Value of Immature Platelet Fraction
NCT07039227 ·Status: COMPLETED
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT00222222 ·Status: COMPLETED ·Phase: NA
-
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 ·Status: TERMINATED
-
German Lactat Clearance in Severe Sepsis
NCT01929772 ·Status: COMPLETED
-
Cerebrovascular Autoregulation During Sepsis
NCT01029080 ·Status: COMPLETED
-
Serial Measurement of Capillary Blood Lactate in the Management of Sepsis
NCT02180399 ·Status: COMPLETED
-
Characterization of the Inflammatory Profile of Patients With Macrophage Activation Syndrome Secondary to Bacterial Sepsis
NCT03721809 ·Status: COMPLETED ·Phase: NA